<DOC>
	<DOC>NCT01177709</DOC>
	<brief_summary>Study hypothesis is that patients on antipsychotics medication treated with metformin will show loss in weight and improved measures of glucose metabolism.</brief_summary>
	<brief_title>Metformin for Weight Loss in Schizophrenia</brief_title>
	<detailed_description>Patients who had gained more than 10 lbs of weight in the last 3 months or had BMI of 35 or greater were treated with metformin up to 200 mg/day in an open label study of up to 3 months time. Changes in weight and glucose measures were recorded.</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Patients will be 1870 years of age; Currently hospitalized or an outpatient at MPC; BMI â‰¥ 35 or excessive recent weight gain ( &gt; than 10 lb weight gain in the past 3 months); Patients will have a diagnosis of schizophrenia or schizoaffective disorder or bipolar disorder. Age below 18 or over 70; Patient is currently already treated with metformin.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>antipsychotics</keyword>
	<keyword>obesity</keyword>
	<keyword>diabetes</keyword>
</DOC>